Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Mar 2023
Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.
Read Full NewsThe pediatric epileptologist at Boston Children’s Hospital discussed national variability in treating infantile epileptic spasms syndrome and the evidence gaps that continue to shape clinical decision making.
Charles Bernick, MD, a staff neurologist at the Cleveland Clinic Lou Ruvo Center for Brain Health, commented on the scientific rationale, therapeutic strategies, and biomarker advances driving the next wave of anti-tau drug development in Alzheimer disease.
Discussing Granuloma Annulare, Lichenoid Disorders, and Social Media, With Shannon Trotter, DO
1.
According to new studies, some cancer patients can safely forego radiation therapy.
2.
A computer-aided diagnostic system for improved detection of breast cancer.
3.
Charles III, King of Kings, is Cancerous.
4.
Adult overdose deaths on the rise
5.
Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.
1.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
2.
Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms
3.
Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making
4.
PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision
5.
Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
3.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge